Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemistry, structure and function of approved oligonucleotide therapeutics
Martin Egli, Muthiah Manoharan
Nucleic Acids Research (2023) Vol. 51, Iss. 6, pp. 2529-2573
Open Access | Times Cited: 370

Showing 1-25 of 370 citing articles:

Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
Marlen C. Lauffer, Willeke M. C. van Roon‐Mom, Annemieke Aartsma‐Rus
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 72
RNAi-based drug design: considerations and future directions
Qi Tang, Anastasia Khvorova
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 5, pp. 341-364
Open Access | Times Cited: 63
RNA‐based medicine: from molecular mechanisms to therapy
Anke Sparmann, Jörg Vogel
The EMBO Journal (2023) Vol. 42, Iss. 21
Open Access | Times Cited: 52
Chemically Modified Platforms for Better RNA Therapeutics
Yesi Shi, Xueyan Zhen, Yiming Zhang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 3, pp. 929-1033
Closed Access | Times Cited: 39
Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation
Jillian Belgrad, Hassan H. Fakih, Anastasia Khvorova
Nucleic Acid Therapeutics (2024) Vol. 34, Iss. 2, pp. 52-72
Closed Access | Times Cited: 30
Click editing enables programmable genome writing using DNA polymerases and HUH endonucleases
Joana Ferreira da Silva, Connor J. Tou, Emily M. King, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 27
Engineering approaches for RNA-based and cell-based osteoarthritis therapies
Carlisle R. DeJulius, Bonnie L. Walton, Juan M. Colazo, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 81-100
Closed Access | Times Cited: 26
Targeted protein degradation directly engaging lysosomes or proteasomes
Jiseong Kim, Insuk Byun, Do Young Kim, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 7, pp. 3253-3272
Open Access | Times Cited: 23
Modern approaches to therapeutic oligonucleotide manufacturing
Richard Obexer, Molhm Nassir, Eddie Moody, et al.
Science (2024) Vol. 384, Iss. 6692
Closed Access | Times Cited: 22
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases
Suxiang Chen, Saumya Nishanga Heendeniya, Bao T. Le, et al.
BioDrugs (2024) Vol. 38, Iss. 2, pp. 177-203
Open Access | Times Cited: 21
Recent advances and current challenges in hydrophilic interaction chromatography for the analysis of therapeutic oligonucleotides
Honorine Lardeux, Valentina D’Atri, Davy Guillarme
TrAC Trends in Analytical Chemistry (2024) Vol. 176, pp. 117758-117758
Open Access | Times Cited: 20
Unravelling the Link between Oligonucleotide Structure and Diastereomer Separation in Hydrophilic Interaction Chromatography
Honorine Lardeux, Kathrin Stavenhagen, Clément Paris, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 24, pp. 9994-10002
Open Access | Times Cited: 20
Frameworks for transformational breakthroughs in RNA-based medicines
John R. Androsavich
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 421-444
Closed Access | Times Cited: 18
Nucleic acid drug and delivery techniques for disease therapy: Present situation and future prospect
Tianjiao Wang, Youhong Tang, Yuandong Tao, et al.
Deleted Journal (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 17
Breaking the mold with RNA—a “RNAissance” of life science
Charles H. Jones, John R. Androsavich, N. So, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Three ‘E’ challenges for siRNA drug development
Shuai Guo, Jun Zhang, Yuanyu Huang
Trends in Molecular Medicine (2023) Vol. 30, Iss. 1, pp. 13-24
Open Access | Times Cited: 25
Acyclic (S)-glycol nucleic acid (S-GNA) modification of siRNAs improves the safety of RNAi therapeutics while maintaining potency
Martin Egli, Mark K. Schlegel, Muthiah Manoharan
RNA (2023) Vol. 29, Iss. 4, pp. 402-414
Open Access | Times Cited: 24
Multispecies-targeting siRNAs for the modulation of JAK1 in the skin
Qi Tang, Katherine Y. Gross, Hassan H. Fakih, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 1, pp. 102117-102117
Open Access | Times Cited: 11
Recent Progress of Small Interfering RNA Delivery on the Market and Clinical Stage
Fan Guo, Yan Li, Wenjun Yu, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 5, pp. 2081-2096
Closed Access | Times Cited: 11
Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?
Henriette Thau, Sebastian Neuber, Maximilian Y. Emmert, et al.
Cardiology and Therapy (2024) Vol. 13, Iss. 1, pp. 39-67
Open Access | Times Cited: 10
A Review on Commercial Oligonucleotide Drug Products
Bhavani Prasad Vinjamuri, Jiayi Pan, Paul Peng
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 7, pp. 1749-1768
Closed Access | Times Cited: 10
Controlled enzymatic synthesis of oligonucleotides
Maëva Pichon, Marcel Hollenstein
Communications Chemistry (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 10
Chemical Synthesis of Modified RNA
Laurin Flemmich, Raphael Bereiter, Ronald Micura
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 22
Open Access | Times Cited: 9
The tale of SOX2: Focusing on lncRNA regulation in cancer progression and therapy
Peng Huang, Feng Wen, YiShan Li, et al.
Life Sciences (2024) Vol. 344, pp. 122576-122576
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top